Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
KMT2D mutation + TMB-H
i
Other names:
KMT2D, Lysine Methyltransferase 2D, Histone-Lysine N-Methyltransferase 2D, Myeloid/Lymphoid Or Mixed-Lineage Leukemia 2, Lysine (K)-Specific Methyltransferase 2D, Trinucleotide Repeat Containing 21, Lysine N-Methyltransferase 2D, ALL1-Related Protein, MLL2, MLL4, ALR, Myeloid/Lymphoid Or Mixed-Lineage Leukemia Protein, Histone-Lysine N-Methyltransferase MLL2, Truncated Lysine Methyltransferase 2D, Kabuki Mental Retardation Syndrome, Kabuki Make-Up Syndrome, CAGL114, KABUK1, TNRC21, AAD10, TMB |
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
8085
Related biomarkers:
Expression
Mutation
Others
‹
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
KMT2D mutation + TMB-H
Non Small Cell Lung Cancer
KMT2D mutation + TMB-H
Non Small Cell Lung Cancer
PD-L1 inhibitor
Sensitive: B - Late Trials
PD-L1 inhibitor
Sensitive
:
B
PD-L1 inhibitor
Sensitive: B - Late Trials
PD-L1 inhibitor
Sensitive
:
B
KMT2D mutation + TMB-H
Non Small Cell Lung Cancer
KMT2D mutation + TMB-H
Non Small Cell Lung Cancer
PD1 inhibitor + CTLA4 inhibitor
Sensitive: B - Late Trials
PD1 inhibitor + CTLA4 inhibitor
Sensitive
:
B
PD1 inhibitor + CTLA4 inhibitor
Sensitive: B - Late Trials
PD1 inhibitor + CTLA4 inhibitor
Sensitive
:
B
KMT2D mutation + TMB-H
Colorectal Cancer
KMT2D mutation + TMB-H
Colorectal Cancer
Immunotherapy
Sensitive: C3 – Early Trials
Immunotherapy
Sensitive
:
C3
Immunotherapy
Sensitive: C3 – Early Trials
Immunotherapy
Sensitive
:
C3
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login